Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kimberly Page

Showing results (201-210 of 222) with videos related to

Pageof 23
Sort By:
Plos One|April 4, 2015
Patterns of hepatitis C virus RNA levels during acute infection: the InC3 studyBehzad Hajarizadeh, Bart Grady, Kimberly Page, et al.
Journal of Medical Internet Research|June 2, 2023
A Video-Observed Treatment Strategy to Improve Adherence to Treatment Among Persons Who Inject Drugs Infected With Hepatitis C Virus: Qualitative Study of Stakeholder Perceptions and ExperiencesAlison Karasz, Krupa Merchant, Julia Arnsten, et al.
Journal of Psychosomatic Research|October 22, 2025
Depression profiles and hepatitis C treatment outcomes among people who inject drugs: The HERO studyIrene Pericot-Valverde, Snehal S Lopes, Jessica Obeysekare, et al.
Harm Reduction Journal|April 22, 2026
Substance use and mental health before versus during COVID-19 pandemic among persons who inject drugs with HCV infection history-the HERO studySnehal S Lopes, Irene Pericot-Valverde, Paula J Lum, et al.
Drug and Alcohol Dependence|July 11, 2024
Effect of self-efficacy among persons who inject drugs treated with direct-acting antivirals on Hepatitis C treatment initiation, duration, completion, adherence, and cureSnehal S Lopes, Irene Pericot-Valverde, J Edward Dotherow, et al.
American Journal of Epidemiology|June 1, 2019
Scaling Up Hepatitis C Prevention and Treatment Interventions for Achieving Elimination in the United States: A Rural and Urban ComparisonHannah Fraser, Claudia Vellozzi, Thomas J Hoerger, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|March 12, 2019
Genomic characterization of hepatitis C virus transmitted founder variants with deep sequencingArunasingam Abayasingam, Preston Leung, Auda Eltahla, et al.
Drug and Alcohol Dependence|March 3, 2025
Patient-navigator working alliance and hepatitis C treatment cascade outcomes among persons who inject drugs: The HERO studySnehal S Lopes, J Edward Dotherow, Irene Pericot-Valverde, et al.
The Journal of Infectious Diseases|April 18, 2015
Hepatitis C Virus Reinfection and Spontaneous Clearance of Reinfection--the InC3 StudyRachel Sacks-Davis, Jason Grebely, Gregory J Dore, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|September 27, 2014
Interferon lambda 3 genotype predicts hepatitis C virus RNA levels in early acute infection among people who inject drugs: the InC(3) studyBehzad Hajarizadeh, Bart Grady, Kimberly Page, et al.
Pageof 23

Showing results (201-210 of 222) with videos related to

Sort By:
Pageof 23
Plos One|April 4, 2015
Patterns of hepatitis C virus RNA levels during acute infection: the InC3 studyBehzad Hajarizadeh, Bart Grady, Kimberly Page, et al.
Journal of Medical Internet Research|June 2, 2023
A Video-Observed Treatment Strategy to Improve Adherence to Treatment Among Persons Who Inject Drugs Infected With Hepatitis C Virus: Qualitative Study of Stakeholder Perceptions and ExperiencesAlison Karasz, Krupa Merchant, Julia Arnsten, et al.
Journal of Psychosomatic Research|October 22, 2025
Depression profiles and hepatitis C treatment outcomes among people who inject drugs: The HERO studyIrene Pericot-Valverde, Snehal S Lopes, Jessica Obeysekare, et al.
Harm Reduction Journal|April 22, 2026
Substance use and mental health before versus during COVID-19 pandemic among persons who inject drugs with HCV infection history-the HERO studySnehal S Lopes, Irene Pericot-Valverde, Paula J Lum, et al.
Drug and Alcohol Dependence|July 11, 2024
Effect of self-efficacy among persons who inject drugs treated with direct-acting antivirals on Hepatitis C treatment initiation, duration, completion, adherence, and cureSnehal S Lopes, Irene Pericot-Valverde, J Edward Dotherow, et al.
American Journal of Epidemiology|June 1, 2019
Scaling Up Hepatitis C Prevention and Treatment Interventions for Achieving Elimination in the United States: A Rural and Urban ComparisonHannah Fraser, Claudia Vellozzi, Thomas J Hoerger, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|March 12, 2019
Genomic characterization of hepatitis C virus transmitted founder variants with deep sequencingArunasingam Abayasingam, Preston Leung, Auda Eltahla, et al.
Drug and Alcohol Dependence|March 3, 2025
Patient-navigator working alliance and hepatitis C treatment cascade outcomes among persons who inject drugs: The HERO studySnehal S Lopes, J Edward Dotherow, Irene Pericot-Valverde, et al.
The Journal of Infectious Diseases|April 18, 2015
Hepatitis C Virus Reinfection and Spontaneous Clearance of Reinfection--the InC3 StudyRachel Sacks-Davis, Jason Grebely, Gregory J Dore, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|September 27, 2014
Interferon lambda 3 genotype predicts hepatitis C virus RNA levels in early acute infection among people who inject drugs: the InC(3) studyBehzad Hajarizadeh, Bart Grady, Kimberly Page, et al.
Pageof 23